Research Use Only
Blends
CJC-1295(no dac)/Ipamorelin 5mg/5mg
SKU: MPCJP
$69.99
Out of Stock
Volume Discount
8% off
$150+ cart
12% off
$250+ cart
18% off
$400+ cart
CJC-1295 (No DAC) + Ipamorelin 5mg/5mg blend in a 10mg lyophilized vial. The combination pairs a GHRH analog with a selective ghrelin receptor agonist for synergistic pulsatile growth hormone release research. Each batch ships with a third-party Certificate of Analysis confirming HPLC purity and mass spec identity for both peptides. For laboratory research only.
Third-Party Tested
Independent lab verification
COA Available
Certificate of Analysis included
Free Shipping
On all domestic orders
Research Use Only
For laboratory research purposes
Product Details
CJC-1295 / Ipamorelin Blend
CJC-1295 / Ipamorelin is a precision-formulated research peptide blend combining CJC-1295 (no DAC) (5mg) and Ipamorelin (5mg) in a single vial. Each vial contains 10mg total of lyophilized peptide blend for research purposes only. Third-party tested with Certificate of Analysis (COA) available. Purity: >99%. COA Batch: MPCJP001.
Description
This blend combines two well-characterized peptides frequently utilized in laboratory settings to explore growth hormone secretagogue pathways:
- CJC-1295 (w/o DAC) is a tetrasubstituted peptide analogue of growth hormone–releasing hormone (GHRH). The "without DAC" modification provides a shorter half-life, allowing study of pulsatile GH release models.
- Ipamorelin is a selective ghrelin receptor agonist studied for its ability to stimulate GH release in vitro without significantly affecting prolactin or cortisol pathways.
Together, this blend offers researchers a complementary model system for investigating GH-related signaling and cellular responses.
Specifications
- Form: Lyophilized powder
- Unit Size: 10mg total (5mg CJC-1295 w/o DAC + 5mg Ipamorelin per vial)
- Storage: Store lyophilized at –20°C. After reconstitution, refrigerate at 2–8°C. Protect from light and moisture.
Application Context
CJC-1295 (w/o DAC) + Ipamorelin is studied in vitro for potential roles in:
- Growth hormone secretagogue pathway modeling
- Pulsatile GH release vs. extended half-life analogues
- Ghrelin receptor agonist selectivity and activity
- Synergistic peptide interactions on pituitary cell assays
- Comparative peptide pharmacology research
Intended Use
This compound is intended strictly for in vitro laboratory research. It is not approved for human or animal consumption and must not be incorporated into food, drugs, supplements, or cosmetics.
Legal Disclaimer
This product and all related information have not been evaluated by the U.S. Food and Drug Administration. No claims are made regarding diagnosis, treatment, cure, or prevention of disease. Use is limited to qualified research professionals in certified laboratory environments.
Terms of Sale
By purchasing from Midwest Peptide, the buyer affirms they are a qualified researcher or institution. The purchaser assumes full responsibility for lawful handling, storage, and application of this material. All sales are final.
Frequently Asked Questions
What is the CJC-1295 / Ipamorelin blend?
+
This research peptide blend combines CJC-1295 (a long-acting GHRH analog) with ipamorelin (a selective ghrelin / GHS-R1a receptor agonist). In research models the two molecules act on parallel pathways of the growth hormone axis. Supplied strictly for Research Use Only.
Is this CJC-1295 with DAC or without DAC?
+
This blend contains CJC-1295 without DAC (no Drug Affinity Complex moiety). Without-DAC CJC-1295 has a shorter circulating half-life than the DAC-modified variant, producing a more pulsatile profile in research models that aligns with co-administration of a GHRP like ipamorelin.
Why are CJC-1295 and ipamorelin studied together?
+
CJC-1295 stimulates pituitary GH release via the GHRH receptor while ipamorelin stimulates the same cells via the GHS-R1a (ghrelin) receptor. Research models show the combined GHRH+GHRP mechanism produces a synergistic GH pulse that neither molecule produces alone.
What is this blend used for in research?
+
Related Products
Other research peptides in this category
Learn More About CJC-1295/Ipamorelin
Research articles and insights related to CJC-1295/Ipamorelin
Ipamorelin and GHS-R1a: Selective Growth Hormone Secretagogue Research
Explore how ipamorelin selectively targets the ghrelin receptor GHS-R1a, its role as a growth hormone secretagogue, and research on cortisol and prolactin.
April 29, 2026
CJC 1295 Ipamorelin Buyer's Guide: Research Use and Sourcing
Learn how to buy CJC 1295 Ipamorelin for research. Explore sourcing options, quality considerations, and compliance for preclinical studies.
April 29, 2026
CJC/Ipa Lean Mass Research: Body Composition Endpoints
CJC-1295 and Ipamorelin lean mass research covering body composition, muscle protein synthesis, fiber cross sectional area, and functional strength endpoints. For research use only.
April 24, 2026
CJC/Ipa and Sleep: Nocturnal GH Pulse Research
CJC-1295 and Ipamorelin sleep growth hormone research covering nocturnal GH pulse amplification, sleep architecture effects, and circadian timing considerations. For research use only.
April 24, 2026
1 / 5
Research Use Only. These products are not supplements, drugs, or intended for human or veterinary use. These products are for laboratory research purposes only. All product information available on this website is for educational purposes only. The products offered on this website are not intended to diagnose, treat, cure, or prevent any disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This material is sold for in-vitro research purposes only.